Stockscreener 앱 받기
83.29
0.11%
0.09
시장 영업 전:
83.80
0.51
+0.61%
전일 마감가:
$83.20
열려 있는:
$82.98
하루 거래량:
7.11M
Relative Volume:
0.71
시가총액:
$106.61B
수익:
$36.36B
순이익/손실:
$4.84B
주가수익비율:
22.35
EPS:
3.7261
순현금흐름:
$5.43B
1주 성능:
-0.34%
1개월 성능:
+4.98%
6개월 성능:
-15.53%
1년 성능:
-7.05%
1일 변동 폭
$82.80
$84.03
1주일 범위
$78.97
$84.79
52주 변동 폭
$73.31
$106.33
메드트로닉 Stock (MDT) Company Profile
명칭
Medtronic Plc
전화
01135314381700
주소
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
83.29 | 106.61B | 36.36B | 4.84B | 5.43B | 3.7261 |
ABT
Abbott Laboratories
|
101.66 | 177.07B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
319.14 | 122.35B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.77 | 65.06B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.00 | 48.94B | 6.30B | 1.07B | 1.09B | 1.8406 |
메드트로닉 Stock (MDT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-13 | 재개 | Barclays | Overweight |
| 2026-02-09 | 업그레이드 | Needham | Hold → Buy |
| 2026-02-03 | 재개 | Citigroup | Buy |
| 2026-01-30 | 재개 | Wells Fargo | Overweight |
| 2026-01-06 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2025-11-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2025-06-30 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-03-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-10-10 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | 재확인 | Oppenheimer | Perform |
| 2024-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2024-08-14 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Sell |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | 다운그레이드 | UBS | Buy → Sell |
| 2023-01-09 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-11-23 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-11-16 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-08-24 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | 개시 | Wolfe Research | Underperform |
| 2022-06-01 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-12-16 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-06-10 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-12-15 | 업그레이드 | Goldman | Sell → Neutral |
| 2020-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | 업그레이드 | Stifel | Hold → Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-05-14 | 다운그레이드 | DZ Bank | Buy → Hold |
| 2020-03-30 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2020-03-25 | 업그레이드 | DZ Bank | Hold → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Sell |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-02 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-06-05 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | 재확인 | Needham | Strong Buy |
| 2019-01-03 | 개시 | Deutsche Bank | Buy |
| 2019-01-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-12-19 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-08-27 | 재확인 | Argus | Buy |
모두보기
메드트로닉 주식(MDT)의 최신 뉴스
Medtronic (MDT) to Announce Q1 FY2027 Earnings on August 18 - GuruFocus
Medtronic to announce financial results for its first quarter of fiscal year 2027 - Investing News Network
Medtronic to report Q1 FY2027 financial results on September 1, 2026 - Pluang
Urology Devices Market Size to Reach USD 80.0 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Medtronic sets Sept. 1 date for its next financial report - Stock Titan
Medtech acquisitions: DePuy Synthes, Medtronic add to portfolios - Today's Medical Developments
Medtronic stock holds steady as diabetes and cardiovascular growth underpin recent earnings - ad-hoc-news.de
Medtronic acquires SPR Therapeutics for USD 650 million - Medical Buyer
Medtronic : and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad - marketscreener.com
Medtronic completes SPR Therapeutics acquisition - MedTech Dive
Medtronic (MDT) Completes SPR Therapeutics Deal To Expand Non Opioid Pain Care - Yahoo Finance
Medtronic stock trades steadily as diabetes and cardiovascular businesses support earnings - ad-hoc-news.de
Medtronic and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad - Big News Network.com
Medtronic completes $650M acquisition of SPR Therapeutics - Investing.com UK
Medtronic And Apollo Hospitals Announce Strategic Partnership To Establish State-Of-The-Art Advanced ICU In Hyderabad. - TRIPURA STAR NEWS
Medtronic Completes $650 Million Acquisition of SPR Therapeutics - marketscreener.com
Medtronic completes $650M acquisition of SPR Therapeutics By Investing.com - Investing.com Canada
Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain - Medtronic
Medtronic Adds 60-Day Pain Therapy Without Permanent Implant - Stock Titan
Medtronic (MDT) Completes SPR Therapeutics Acquisition To Expand Non Opioid Pain Care - Sahm
Medtronic plc completed the acquisition of SPR Therapeutics, Inc. - marketscreener.com
Medtronic faces first trial in US hernia mesh injury cases - Reuters
Medtronic PLC (NYSE:MDT): A Top Dividend Stock for Quality and Income Investors - ChartMill
Medtronic PLC stock underperforms Tuesday when compared to competitors - MSN
Is Medtronic PLC (MDT) a Bargain After 5.1% Drop? GF Value Says Undervalued - GuruFocus
Medtronic recalls heart valve delivery catheter for risk of tip detaching - MedTech Dive
FDA Flags Medtronic Harmony Catheter Recall As Class I Over Tip Detachment - insights.citeline.com
Baird Adjusts Price Target on Medtronic to $91 From $85, Maintains Neutral Rating - marketscreener.com
BTIG Research Adjusts Medtronic Price Target to $91 From $90, Maintains Buy Rating - marketscreener.com
Comprehensive Nerve Repair Biomaterials Market Report Published, Profiles Medtronic, Stryker, Boston Scientific, and 20 Other Key Players - Yahoo Finance
Medtronic Plc (MDT) Stock Analysis: A 15.66% Potential Upside In The Healthcare Sector - DirectorsTalk Interviews
Medtronic PLC (XSWX:MDT) Stock Price, Trades & News - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
Medtronic (MDT) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Medtronic PLC stock outperforms competitors on strong trading day - MarketWatch
Medtronic (MDT) Shares Surge on Reimbursement Hopes for Renal De - GuruFocus
MDT stock holds steady as medical technology demand supports long term growth - ad-hoc-news.de
Medtronic gains on coverage hopes for renal denervation (MDT) - Seeking Alpha
Medtronic (MDT) Receives Positive News from AMA CPT Panel on Ren - GuruFocus
TD Cowen cuts Medtronic stock price target on TAVR headwinds By Investing.com - Investing.com Nigeria
Medtronic: Undervalued, And The Tailwinds Are Just Getting Started (NYSE:MDT) - Seeking Alpha
Medtronic: Guidance Built To Be BeatenBuy - Seeking Alpha
TD Cowen Adjusts Price Target on Medtronic to $100 From $119 - marketscreener.com
Medtronic (MDT) Could Be 9% Undervalued On Recall News - Yahoo Finance
Regeneron Cites Medtronic Ruling In Amgen Bundling Case - Law360
Insider Sell: Matthew Walter Sells Shares of Medtronic PLC - GuruFocus
Medtronic (MDT) HR chief sells 3,102 shares, retains over 35,000 - Stock Titan
Global Orthopedic Surgical Robots Market Report Published — Profiles Stryker, Zimmer Biomet, DePuy Synthes, and Medtronic - Yahoo Finance UK
Medtronic: A Near Decade High Dividend For This Aristocrat (NYSE:MDT) - Seeking Alpha
Medtronic plc highlights global medtech reach as a leading implantable device maker - Ad-hoc-news.de
Medtronic (MDT) Following Octopus 4 Recall Has An Undervalued Narrative Under Review - simplywall.st
메드트로닉 (MDT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.23%
0.97%
자본화:
|
볼륨(24시간):